CD40LG and metabolic dysfunction-associated steatotic liver disease: A recent work by Ma et al. demonstrated that the inhibition of the P2Y12 receptor on platelets can promote tumor growth via CD40L in mice with NAFLD [139]; however, there are conflicting data on this mechanism in the literature.